SCHEMBL3581435

SCHEMBL3581435

CCNc1ccc(Cl)cc1C(=O)N(CCc1ccc(F)cc1)Cc1ccc(C(C)(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
NLRP3 Q96P20 1/20 0.41
SERPINE1 P05121 1/20 0.39
C5AR1 P21730 1/20 0.39
ESRRG P62508 2/20 0.38
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
KCNH2 Q12809 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ESRRB O95718 1/20 0.37
CNR1 P21554 2/20 0.36
MCHR1 Q99705 1/20 0.36
SOAT1 P35610 1/20 0.36
F2 P00734 1/20 0.36
F10 P00742 1/20 0.36
F7 P08709 1/20 0.36
CCR9 P51686 3/20 0.36
CCR2 P41597 1/20 0.35
HSP90AA1 P07900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3581531 0.94 C5AR1 (0.43) SERPINE1C5AR1ESRRGLMNAHTT
SCHEMBL2385645 0.90 TP53 (0.42) TP53MAPTESRRGSMN1; SMN2MCHR1
SCHEMBL3571600 0.87 LMNA (0.42) SERPINE1C5AR1LMNASMN1; SMN2CNR1
SCHEMBL3576208 0.86 NLRP3 (0.42) NLRP3C5AR1LMNACCR9LPAR1
SCHEMBL3587697 0.86 C5AR1 (0.41) NLRP3C5AR1LMNAF10HSP90AA1
SCHEMBL3586617 0.86 C5AR1 (0.41) NLRP3C5AR1LMNAF10HSP90AA1
SCHEMBL3584396 0.84 C5AR1 (0.44) SERPINE1C5AR1ESRRGLMNAHTT
SCHEMBL3583813 0.84 CNR1 (0.41) C5AR1CNR1LPAR1LPAR5
SCHEMBL3569921 0.82 SERPINE1 (0.47) SERPINE1C5AR1ESRRGLMNAHTT
SCHEMBL3577122 0.82 NLRP3 (0.42) NLRP3C5AR1F2F10F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US claimed
EP-1984340-B1 ANTHRANILAMIDE/2-AMINO-HETEROARENE CARBOXAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2012-06-27 EP disclosed